Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3006567	du-cl	— (—)	81	93	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other disorders of fluid, electrolyte and acid-base balance

31.95

64.82

1.2

—

Hypokalaemia

70.36

36.95

1.0

1.2

—

Metabolic disorders

9.12

23.96

1.2

1.1

—

Secondary hypertension

+∞

8.29

1.1

0.0

—

Disorders of other endocrine glands

6.44

7.00

1.1

—

Endocrine, nutritional and metabolic diseases

8.08

6.51

1.4

1.2

—

Cardiac arrhythmias

4.12

5.95

1.1

—

Mood disorders, excluding more controls

3.40

5.53

1.0

1.1

—

Other heart diseases, wide

3.24

5.44

1.1

1.2

—

Gastro-oesophageal reflux disease

3.31

5.40

1.1

—

Migraine

4.98

5.31

1.1

—

Other arrhythmias

3.43

4.70

1.1

—

Diaphragmatic hernia

5.00

4.62

1.2

1.1

—

Mood [affective] disorders

2.74

4.48

1.0

1.2

—

Mood disorders

2.74

4.46

1.0

1.2

—

Hypertensive diseases

3.61

4.33

1.1

1.2

—

Hypertension

3.61

4.33

1.1

1.2

—

Hypertensive diseases (excluding secondary)

5.82

4.32

1.1

—

Other heart diseases

5.57

4.31

1.1

1.4

—

Benzodiazepine use

2.72

4.30

1.0

1.2

—

Any mental disorder

2.90

4.18

1.2

1.1

—

Migraine with aura

6.92

4.15

1.1

1.2

—

Symptoms and signs involving the urinary system

2.98

3.84

1.1

—

Anxiety disorders, excluding more controls

2.93

3.59

1.1

—

Noninfective enteritis and colitis

3.71

3.58

1.5

1.1

—

Diseases of oesophagus, stomach and duodenum

2.47

3.50

1.1

1.2

—

Headache

2.87

3.45

1.2

1.0

—

Depression

2.51

3.41

1.0

1.2

—

Cardiovascular diseases

4.24

3.38

1.5

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.48

3.36

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

4.04

3.29

1.1

1.4

—

Neurotic, stress-related and somatoform disorders

2.50

3.28

1.1

1.2

—

Other diseases of intestines

2.49

3.21

1.4

1.1

—

Hypertension, essential

3.16

3.20

1.1

1.2

—

Pure hypercholesterolaemia

3.81

3.19

1.1

—

Anxiety disorders

2.45

3.14

1.1

1.2

—

Irritable bowel syndrome

5.00

3.05

1.0

1.1

—

Other noninfective gastroenteritis and colitis

5.00

3.04

1.6

1.1

—

Vasomotor and allergic rhinitis

4.19

2.92

1.0

1.1

—

Other disorders of lacrimal gland

3.71

2.87

1.1

—

Disorders of lacrimal system

3.38

2.84

1.1

—

Cerebral palsy and other paralytic syndromes

8.34

2.75

1.0

—

Implicit Sepsis

2.51

2.70

1.1

—

Intracranial trauma

3.00

2.70

1.1

1.3

—

Migraine without aura

6.00

2.69

1.0

1.1

—

Abnormalities of breathing

2.49

2.66

1.1

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.60

2.65

1.4

1.1

—

Triptan medication for migraine, min. 3 purchases

2.77

2.65

1.1

—

Other soft tissue disorders, not elsewhere classified

2.35

2.64

1.2

—

Sleep apnoea

2.30

2.61

1.1

1.2

—

Abnormalities of heart beat

3.64

2.58

1.0

—

Unspecified privation

7.15

2.55

1.0

—

Personality disorders, excluding more controls

5.44

2.53

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

3.18

2.49

1.1

—

Disturbances of skin sensation

3.81

2.46

1.1

—

Asthma

2.50

2.46

1.0

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.33

2.45

1.4

1.1

—

Anxiety (asthma-related co-morbidities)

2.76

2.45

1.1

1.3

—

Asthma (mode)

2.47

2.42

1.0

1.3

—

Excessive earwax

2.56

2.41

1.2

1.1

—

Migraine with aura and triptan purchases

5.00

2.40

1.2

1.1

—

Benign thyroid growths and nodules

3.35

2.37

1.0

—

Atrial fibrillation and flutter

5.53

2.37

1.0

—

Myalgia

4.12

2.36

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2.17

2.33

1.1

—

Asthma, excluding more controls

2.48

2.28

1.0

1.3

—

Other reaction to severe stress, and adjustment disorders

3.48

2.26

1.1

1.0

—

Substance abuse, excluding more controls

2.98

2.26

1.1

—

Dyspnoea

2.16

2.25

1.1

—

Implicit viral Sepsis

3.89

2.25

1.1

—

Viral Sepsis

3.89

2.25

1.1

—

Gastroduodenal ulcer

3.88

2.24

1.1

—

Pollen allergy

4.55

2.24

1.0

1.1

—

All kidney diseases

2.12

2.23

1.4

1.1

—

Hypertrophy of breast

5.56

2.21

1.0

—

Atopic dermatitis, strict definition with reimbursement

3.34

2.17

1.1

—

Exposure to unspecified factor

2.08

2.15

1.1

1.2

—

Other anxiety disorders

3.06

2.15

1.1

1.2

—

Concussion

2.87

2.14

1.0

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

4.01

2.14

1.1

—

Other functional intestinal disorders

3.03

2.14

1.0

1.1

—

Other disorders of urethra and urinary system

2.37

2.13

1.0

1.1

—

Pain in throat and chest

2.34

2.12

1.2

—

ILD medications

2.07

2.12

1.5

1.1

—

Diseases of the digestive system

2.76

2.11

1.2

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2.16

2.11

1.2

1.1

—

All anxiety disorders

2.52

2.10

1.1

1.2

—

Other disorders of breast

5.00

2.07

1.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

2.36

2.05

1.1

—

Intestinal infectious diseases

2.11

2.03

1.4

1.1

—

Hyperparathyroidism

3.96

2.01

1.2

1.0

—

Urolithiasis

3.08

2.01

1.6

1.1

—

Pain in joint

2.79

2.01

1.1

1.0

—

Spondylopathies

2.20

2.00

1.4

1.1

—

Implicit Sepsis, including avohilmo

2.16

2.00

1.1

—

Nausea and vomiting

3.41

2.00

1.7

1.1

—

Extrapyramidal and movement disorders

2.81

1.99

1.1

—

Acetic acid derivatives and related substances

4.43

1.96

1.8

1.3

—

Hernia

2.09

1.95

1.2

—

Persistent mood disorders

4.55

1.94

1.0

1.2

—

Hypertrophy of breast in women and men

4.55

1.94

1.0

—

Gastric ulcer

4.55

1.94

1.0

—

General symptoms and signs

2.10

1.94

1.4

1.0

—

Sleep apnoea, including avohilmo

2.05

1.93

1.1

1.2

—

Carbimazole or st.post thyroidectomy, condition for graves disease

3.75

1.93

1.0

—

Other diseases of blood and blood-forming organs, wide

3.75

1.93

1.2

1.1

—

Obesity related asthma

2.96

1.93

1.0

1.2

—

Alcohol use disorder, ICD-based

2.73

1.93

1.0

1.2

—

Recurrent or chronic depression

2.84

1.92

1.1

—

Disorders of parathyroid gland

3.71

1.91

1.2

1.0

—

Antihypertensive medication - note that there are other indications

3.21

1.90

1.1

1.4

—

Asthma (diagnoses ohter than nonallergic)

2.08

1.90

1.0

1.2

—

Nontoxic goitre/thyroid nodule

3.18

1.88

1.0

—

Inflammatory bowel disease

3.18

1.88

2.0

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

3.18

1.87

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

2.09

1.87

1.5

1.1

—

Missing teeth due to accident, extraction or parodontitis

2.33

1.87

1.3

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.09

1.86

1.1

—

Disorders of breast

2.42

1.84

1.0

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2.62

1.84

1.0

1.1

—

Sulfasalazine

3.53

1.83

1.8

1.1

—

Atopic dermatitis, strict definition

3.11

1.83

1.0

1.1

—

Migraine without aura and triptan purchases

4.17

1.82

1.0

1.1

—

Valvular heart disease excluding rheumatic fever

2.68

1.81

1.2

1.1

—

Non-rheumatic valve diseases

2.67

1.81

1.2

1.1

—

Bleeding

2.18

1.80

1.1

—

Persons encountering health services in other circumstances, wide

1.94

1.80

1.4

1.1

—

Asthma (only as main-diagnosis), excluding more controls

2.32

1.80

1.0

1.3

—

Other headache syndromes

2.75

1.78

1.0

1.1

—

Episodal and paroxysmal disorders

2.05

1.76

1.1

1.2

—

Any reimbursement code in KELA

2.78

1.75

1.0

1.1

—

Other specific joint derangements/joint disorders

2.25

1.75

1.1

—

Atopic dermatitis

2.27

1.74

1.1

—

L04AA Selective immunosuppressants

3.33

1.74

1.3

1.1

—

Osteopathies and chondropathies

2.34

1.74

1.0

1.1

—

Melanocytic naevi

2.92

1.72

1.4

1.0

—

First line medication for Crohn's disease

1.93

1.71

1.5

1.1

—

Neurological diseases

2.20

1.69

1.1

1.3

—

Asthma, unspecified (mode), excluding more controls

2.55

1.68

1.0

1.1

—

Malaise and fatigue

2.54

1.67

1.1

1.0

—

Use of pramipexole

3.16

1.66

1.2

1.1

—

Other extrapyramidal and movement disorders in other diseases

3.16

1.66

1.0

1.1

—

Alcohol dependence

3.16

1.66

1.0

1.1

—

All influenza

3.16

1.66

1.2

1.1

—

Other viral diseases

3.15

1.65

1.2

—

Other arthritis (FG)

2.80

1.65

1.7

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.92

1.63

1.2

1.1

—

Asthma (only as main-diagnosis)

2.20

1.63

1.0

1.2

—

ILD medications: immunosuppressive drugs

2.17

1.63

1.7

1.1

—

Oxicams

4.06

1.62

1.0

1.3

—

Thyrotoxicosis with diffuse goitre

3.57

1.61

1.0

—

Disorders of eyelid, lacrimal system and orbit

1.95

1.61

1.2

1.1

—

Asthma, unspecified (mode)

2.40

1.61

1.0

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.35

1.59

1.0

1.1

—

Benign neoplasm: Colon

2.35

1.59

1.2

1.1

—

Other diseases of the digestive system

2.69

1.58

1.1

1.0

—

Implicit viral Sepsis, including avohilmo

2.69

1.57

1.1

—

Polyarthropathies

2.20

1.56

1.5

1.1

—

Senile cataract

2.21

1.56

1.2

1.1

—

Chronic lower respiratory diseases

1.81

1.53

1.0

1.2

—

Injury of muscle and tendon at shoulder and upper arm level

2.59

1.51

1.1

—

Coxibs

3.75

1.51

1.0

1.3

—

Personality disorders

2.86

1.50

1.0

1.1

—

Other and unspecified effects of external causes

2.86

1.50

1.0

1.1

—

Epilepsy

2.85

1.50

1.0

1.1

—

Diseases of the respiratory system

2.30

1.47

1.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

2.42

1.47

1.0

1.1

—

Ischaemic heart disease, wide definition

2.00

1.46

1.1

—

Influenza and pneumonia

1.82

1.45

1.1

1.2

—

Anti-inflammatory and antirheumatic products, non-steroids

3.59

1.45

1.0

1.3

—

Phlebitis and thrombophlebitis (not including DVT)

3.13

1.44

1.0

1.1

—

Specific personality disorders

3.13

1.44

1.0

1.1

—

Spondylosis

2.15

1.43

1.0

1.1

—

Pain in limb

1.98

1.42

1.3

1.1

—

Depression or dysthymia

2.22

1.42

1.1

—

Allergic rhinitis

2.69

1.41

1.0

1.4

—

Mental and behavioural disorders due to alcohol

2.26

1.40

1.0

1.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.80

1.37

1.4

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.84

1.37

1.1

—

Visual disturbances and blindness

2.19

1.36

1.0

1.1

—

Hyperlipidaemia, other/unspecified

2.99

1.36

1.0

1.1

—

Ischemic heart diseases

1.90

1.36

1.2

1.0

—

Substance abuse

2.16

1.36

1.1

1.2

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1.79

1.36

1.0

1.1

—

Acute alcohol intoxication

2.94

1.36

1.0

1.1

—

Coxarthrosis

2.23

1.35

1.1

—

Care involving use of rehabilitation procedures

2.00

1.35

1.1

—

Emergency coronary revascularization (for ACS)

1.89

1.34

1.1

—

Nutritional anaemias

2.14

1.33

1.0

1.1

—

Intracranial injury

2.12

1.30

1.1

1.2

—

Alcohol use disorder, Swedish definition

2.10

1.29

1.0

1.1

—

Polyuria

2.78

1.28

1.0

1.1

—

Gout, idiopatic and unspecified

2.78

1.28

1.2

—

Finngen Rheumatological endpoints

1.85

1.26

1.5

1.1

—

Asthma, including avohilmo

1.71

1.26

1.0

1.2

—

Other degenerative diseases of the nervous system

2.80

1.24

1.0

—

Calculus of kidney and ureter

2.40

1.24

1.8

1.1

—

GI-bleeding

2.40

1.24

1.2

1.0

—

Pneumonia, organism unspecified

1.80

1.23

1.1

1.2

—

Injuries to the shoulder and upper arm

1.83

1.22

1.1

1.2

—

Inflammatory bowel disease treatment related agents

1.72

1.22

1.5

1.1

—

Impingement syndrome of shoulder

2.63

1.21

1.2

1.1

—

Subjective visual disturbances

2.63

1.21

1.0

1.1

—

Adverse effects, not elsewhere classified

2.63

1.21

1.0

1.1

—

Paralytic ileus and intestinal obstruction

2.63

1.21

2.2

1.1

—

Injuries to the hip and thigh

2.17

1.21

1.0

1.1

—

Tramadol

1.91

1.21

1.2

1.1

—

Percutaneous Coronary Intervention

1.85

1.20

1.1

1.0

—

Coronary revascularization (ANGIO or CABG)

1.85

1.20

1.1

1.0

—

Basal cell carcinoma

2.18

1.20

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.17

1.19

1.1

—

Basal cell carcinoma, including Hilmo

2.17

1.19

1.1

—

Spontaneous abortion

2.14

1.18

1.0

1.1

—

Disorders of skin appendages

2.09

1.17

1.3

1.2

—

Gout

2.52

1.14

1.2

1.1

—

Fracture of femur

2.50

1.14

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2.08

1.14

1.1

—

Mental and behavioural disorders due to psychoactive substance use

1.99

1.13

1.1

1.2

—

Constipation

1.75

1.13

1.0

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.72

1.13

1.1

1.2

—

Certain infectious and parasitic diseases, including avohilmo

1.94

1.12

1.0

1.2

—

Hypothyroidism, strict autoimmune

1.95

1.11

1.0

1.1

—

Rotator cuff syndrome

1.94

1.11

1.1

—

Diverticular disease of intestine

1.96

1.11

1.2

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.96

1.11

1.0

1.1

—

Psychiatric diseases

1.86

1.09

1.2

1.1

—

Visual disturbances

1.95

1.08

1.0

1.1

—

Gout, FINNGEN

2.37

1.08

1.2

1.1

—

Examination and observation for other reasons

2.01

1.06

1.2

1.0

—

Shoulder lesions

1.81

1.06

1.1

—

Cholecystectomy

1.82

1.06

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

1.69

1.06

1.1

—

Other obstetric conditions, not elsewhere classified

2.43

1.05

1.2

1.1

—

Mouth breathing

2.12

1.05

1.0

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.42

1.05

1.2

1.1

—

Other diseases of upper respiratory tract

1.70

1.05

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

1.80

1.04

1.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1.85

1.04

1.5

1.1

—

Heart failure, not strict

1.83

1.04

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.78

1.04

1.0

1.1

—

Cholelithiasis

1.74

1.04

1.1

—

Iron deficiency anaemia

2.08

1.03

1.0

1.1

—

1.96

1.03

1.0

1.2

—

Thyrotoxicosis

2.27

1.03

1.0

—

Other specified/unspecified arthritis

2.27

1.03

2.0

1.1

—

Disorders of adult personality and behaviour

2.27

1.03

1.0

1.1

—

Reimbursement for rheumatic diseases

1.94

1.03

1.8

1.1

—

Coxarthrosis [arthrosis of hip](FG)

1.93

1.02

1.1

—

Other disorders of veins

2.03

1.01

1.7

1.1

—

Dizziness and giddiness

1.79

1.01

1.1

—

Retention of urine

2.25

0.99

1.0

1.2

—

Chronic sinusitis

2.00

0.99

1.1

—

Persons encountering health services for specific procedures and health care

1.66

0.99

1.1

1.2

—

Necrosis of pulp, including avohilmo

1.86

0.98

1.0

1.1

—

1.82

0.97

1.0

1.3

—

Unspecified haematuria

1.96

0.97

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

1.71

0.97

1.0

1.2

—

Major coronary heart disease event

1.71

0.97

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

1.63

0.96

1.1

1.2

—

Other abnormal products of conception

2.32

0.95

1.2

1.1

—

All pneumoniae

1.62

0.95

1.1

1.2

—

Other cataract

1.93

0.94

1.1

—

Benign neoplasms

1.67

0.94

1.3

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.84

0.92

1.2

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.14

0.91

1.0

1.1

—

Diseases of liver

2.14

0.91

1.2

1.1

—

Other and unspecified disorders of vitreous body

1.85

0.91

1.3

1.1

—

Other viral diseases, including avohilmo

2.12

0.91

1.2

1.3

—

Diseases of salivary glands

2.07

0.89

1.2

1.1

—

Spinal stenosis

1.90

0.88

1.1

—

Disease of hard tissues of teeth, NOS

1.87

0.88

1.2

1.1

—

Malignant neoplasm of skin

1.87

0.87

1.1

—

Cholelithiasis, broad definition with cholecystitis

1.63

0.86

1.1

—

Autoimmune diseases related-to ILD

1.64

0.85

1.6

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.64

0.85

1.1

—

1.64

0.85

1.1

—

Zoster [herpes zoster], including avohilmo

1.79

0.84

1.1

—

Artrosis, including avohilmo

1.77

0.84

1.0

1.1

—

Intestinal stricture

1.94

0.84

2.2

1.0

—

Asthma/COPD (KELA code 203)

1.61

0.83

1.0

1.2

—

Abdominal and pelvic pain

1.67

0.82

1.5

1.1

—

In situ neoplasms

1.88

0.81

1.2

1.0

—

Other inflammation of eyelid, including avohilmo

1.87

0.81

1.3

1.1

—

Coxarthrosis, primary

1.70

0.80

1.1

—

Parasetamol

1.80

0.80

1.1

1.4

—

Nonsuppurative otitis media, including avohilmo

0.00

0.80

0.0

1.3

—

Disorders of vitreous body

1.69

0.80

1.3

1.1

—

Autoimmune diseases

1.61

0.79

1.6

1.1

—

Disorders of vitreous body and globe

1.68

0.79

1.3

1.1

—

Presence of other devices

0.00

0.79

0.0

1.0

—

Temporomandibular joint disorders, including avohilmo

1.82

0.79

1.2

1.1

—

Diseases of arteries, arterioles and capillaries

1.75

0.78

1.1

—

Other and unspecified dermatitis

1.67

0.78

1.3

1.1

—

Myocardial infarction, without ST-elevation

1.80

0.78

1.0

1.1

—

Hypothyroidism, other/unspecified

1.61

0.77

1.0

1.1

—

Gastrointestinal diseases

1.95

0.77

1.0

1.1

—

Sciatica+with lumbago

1.73

0.76

1.1

—

Female infertility

2.14

0.75

1.0

1.1

—

Oedema, not elsewhere classified

2.12

0.75

1.2

1.0

—

Asthma-related pneumonia

2.08

0.74

1.0

1.1

—

Asthma, hospital admissions 3, pneumonia

2.08

0.74

1.0

1.1

—

Asthma-related pneumonia or sepsis

2.08

0.74

1.0

1.1

—

Coronary atherosclerosis

1.62

0.72

1.2

1.1

—

Any dementia, excluding more controls

2.02

0.72

1.0

—

Disorders of lens

1.66

0.72

1.2

1.1

—

Oxycodone

1.94

0.71

1.0

—

Other medical care

1.68

0.68

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.85

0.68

1.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

1.85

0.68

1.0

1.1

—

Abrasion of teeth

1.85

0.68

1.2

1.1

—

Other and unspecified iron deficiency

1.85

0.68

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.55

0.67

1.0

1.1

—

Symptoms and signs involving speech and voice

1.79

0.66

1.0

—

Candidiasis, including avohilmo

1.79

0.66

1.2

1.1

—

Obesity, other/unspecified

1.79

0.66

1.0

1.1

—

Primary open-angle glaucoma

1.78

0.66

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.61

0.66

1.0

1.1

—

Other antidepressants

1.52

0.65

1.1

1.2

—

Asthma, hospital admission 2, infections

1.59

0.65

1.0

1.1

—

Asthma-related infections

1.59

0.65

1.0

1.1

—

COPD differential diagnosis

1.62

0.64

1.1

1.3

—

ILD differential diagnosis

1.62

0.64

1.1

1.3

—

Systemic connective tissue disorders

1.72

0.64

1.2

1.1

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.51

0.63

1.1

1.2

—

Other intervertebral disc disorders

1.55

0.63

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.70

0.63

1.0

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

1.65

0.62

1.6

1.1

—

Irregular menses

1.62

0.62

1.0

1.1

—

L04AX Other immunosuppressants

1.63

0.62

1.3

1.1

—

Premature rupture of membranes

0.00

0.62

0.0

1.0

—

Keratitis

1.67

0.61

1.2

1.1

—

Non-selective monoamine reuptake inhibitors

1.65

0.61

1.2

1.1

—

Colorectal cancer

0.00

0.60

0.0

1.1

—

Angina pectoris

1.56

0.60

1.1

—

Second line medication for Crohn's disease

1.57

0.60

1.3

1.1

—

Nerve, nerve root and plexus disorders

1.45

0.60

1.1

—

Noninflammatory disorders of female genital tract

1.77

0.59

1.2

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.54

0.59

1.2

—

Any gastric operation

1.58

0.59

1.1

—

GASTRO-related operations

1.58

0.59

1.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.74

0.58

1.2

1.1

—

Syncope and collapse

1.73

0.58

1.2

1.0

—

Peripheral artery disease

1.69

0.57

1.2

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.58

0.54

1.0

1.1

—

Aplastic and other anaemias

1.57

0.54

1.3

1.1

—

Carpal tunnel syndrome

1.47

0.53

1.0

1.1

—

Type 2 diabetes, wide definition

1.51

0.52

1.0

1.1

—

Inflammatory diseases of female pelvic organs

1.43

0.52

1.1

1.0

—

Hard cardiovascular diseases

1.48

0.52

1.1

—

Acute upper respiratory infections

1.42

0.51

1.2

1.1

—

Pain (limb, back, neck, head abdominally)

1.59

0.50

1.1

1.0

—

Selective serotonin reuptake inhibitors

1.44

0.49

1.1

1.2

—

Other disorders of ear

1.42

0.49

1.2

1.1

—

Other diseases of urinary system

1.43

0.49

1.2

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.56

0.49

1.0

1.2

—

Contraceptive management

1.53

0.48

1.1

—

Venous thromboembolism

1.53

0.48

1.1

—

Malignant neoplasm of skin, including Hilmo

1.51

0.48

1.1

—

Acute sinusitis

1.51

0.48

1.3

1.2

—

Complications of procedures, not elsewhere classified

0.59

0.46

1.0

1.1

—

Used for control exclusion in common control thyroid runs

1.44

0.46

1.6

1.1

—

Allergic conjunctivitis

1.43

0.46

1.0

1.2

—

Postmenopausal bleeding

1.74

0.45

1.0

1.1

—

Cystitis

1.45

0.45

1.1

—

Use of hypnotics and sedatives

1.38

0.45

1.1

—

Urinary track infection

1.48

0.44

1.1

1.0

—

Other bacterial diseases, including avohilmo

1.36

0.43

1.5

1.1

—

Injuries to the head

1.35

0.43

1.1

1.2

—

Retinal detachments and breaks

1.61

0.43

1.0

1.1

—

Unspecified mental disorder

1.61

0.43

1.0

1.3

—

Persons encountering health services in other circumstances

1.60

0.42

1.2

1.1

—

Any dementia

1.57

0.42

1.0

—

Excluding asthma or asthma-COPD overlap

1.47

0.42

1.1

1.2

—

Other pulmonary diagnosis

1.47

0.42

1.1

1.2

—

Opioids

1.41

0.42

1.1

1.2

—

Embedded and impacted teeth

0.00

0.41

0.0

1.5

—

Arthrosis

1.37

0.41

1.0

1.1

—

Nonsuppurative otitis media

0.00

0.41

0.0

1.5

—

Varicose veins

1.37

0.41

1.0

1.1

—

Conjunctivitis

1.44

0.41

1.1

1.2

—

Malignant neoplasm of colon

0.00

0.41

0.0

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.41

0.0

1.1

—

Follicular cysts of skin and subcutaneous tissue

0.00

0.41

0.0

1.1

—

Disorders of the thyroid gland

1.39

0.41

1.0

1.1

—

Malignant melanoma, including Hilmo

0.00

0.41

0.0

1.0

—

Endometriosis ASRM stages 1,2

0.00

0.41

0.0

1.1

—

Poisoning by medicine

0.00

0.41

0.0

1.1

—

Medical treatment for female infertility

0.00

0.41

0.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

0.00

0.40

0.0

1.1

—

Other and unspecified anaemias

1.47

0.40

1.2

1.1

—

Other anaemias

1.46

0.40

1.2

1.1

—

Other joint disorders

1.45

0.40

1.1

—

Gingivitis and periodontal diseases

1.37

0.40

1.2

1.1

—

Colorectal adenocarcinoma

0.00

0.40

0.0

1.1

—

Dermatitis

1.30

0.39

1.3

1.1

—

Pre-eclampsia

0.00

0.39

0.0

1.1

—

Sequelae with surgical and medical care as external cause

0.00

0.39

0.0

1.1

—

Superficial injury of wrist and hand

0.00

0.39

0.0

1.1

—

Suicide or other Intentional self-harm

0.00

0.39

0.0

1.1

—

Poisoning by drugs, medicaments and biological substances

0.00

0.39

0.0

1.1

—

Sensorineural hearing loss

1.36

0.39

1.2

1.0

—

Erysipelas, including avohilmo

1.36

0.38

1.0

1.1

—

Sleep disorders (combined)

1.36

0.38

1.1

1.2

—

Pregnancy hypertension

1.40

0.38

1.0

1.1

—

Other diseases of lip and oral mucosa

1.39

0.38

1.2

1.1

—

Other nutritional deficiencies

1.33

0.37

1.1

—

Coxarthrosis, primary, with hip surgery

1.36

0.37

1.2

1.1

—

Injuries to the ankle and foot

1.40

0.37

1.0

1.2

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.30

0.37

1.1

1.2

—

Triptan medication for migraine, single purchase ok

1.30

0.37

1.1

1.2

—

Low back pain

1.41

0.37

1.0

1.1

—

Acute appendicitis

1.26

0.36

1.1

1.2

—

Disorders of vestibular function (Vertigo)

1.46

0.36

1.2

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.43

0.36

1.2

1.0

—

Renal tubulo-interstitial diseases

1.37

0.35

1.2

1.1

—

Implicit bacterial Sepsis, including avohilmo

1.43

0.35

1.3

1.1

—

Fever of other and unknown origin

1.37

0.34

2.2

1.0

—

Dorsalgia

0.66

0.34

1.2

1.1

—

Lower back pain or/and sciatica

1.30

0.33

1.1

1.2

—

Oral corticosteroids

1.31

0.33

1.2

1.1

—

Soft tissue disorders

1.34

0.33

1.2

—

Certain infectious and parasitic diseases

1.34

0.32

1.1

—

Codeine or tramadol medication

1.29

0.31

1.1

1.2

—

Fall on same level

1.29

0.31

1.1

1.2

—

General examination and investigation of persons without complaint and reported diagnosis

1.30

0.31

1.4

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.27

0.30

1.3

1.0

—

Presence of other functional implants

1.26

0.30

1.0

1.1

—

Dermatitis and eczema

1.27

0.30

1.5

1.1

—

Injuries to the wrist and hand

0.74

0.29

1.0

1.2

—

Pregnancy with abortive outcome

1.34

0.29

1.0

1.1

—

Disorders of conjunctiva

1.31

0.29

1.1

1.2

—

Persons encountering health services in circumstances related to reproduction

1.31

0.28

1.8

1.0

—

Injuries to the knee and lower leg

0.77

0.27

1.0

1.2

—

Arthropathies

1.26

0.26

1.6

1.1

—

Conductive and sensorineural hearing loss

1.27

0.26

1.2

1.0

—

Dentofacial anomalies [including malocclusion]

1.26

0.26

1.1

1.2

—

Polycystic ovarian syndrome, consortium definition

1.20

0.25

1.0

1.1

—

Appendicitis, broad definition

1.19

0.24

1.1

1.2

—

Diseases of appendix

1.17

0.24

1.1

1.2

—

Type 2 diabetes, definitions combined, including avohilmo

1.26

0.24

1.1

—

Other dorsopathies, not elsewhere classified

0.76

0.23

1.1

—

Implicit bacterial Sepsis

1.34

0.23

1.4

1.1

—

Other disorders of eyelid

1.35

0.23

1.4

1.1

—

Explicit Sepsis

1.34

0.23

1.4

1.1

—

Dementia

1.31

0.23

1.0

—

Explicit Sepsis, including avohilmo

1.33

0.23

1.4

1.1

—

Renal failure

1.29

0.23

1.4

1.1

—

Viral infections characterized by skin and mucous membrane lesions

1.28

0.23

1.2

1.1

—

Insomnia

0.73

0.22

1.3

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.27

0.22

1.0

1.1

—

Presence of cardiac and vascular implants and grafts

1.23

0.22

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

1.28

0.22

1.6

1.1

—

Dental pulpitis, including avohilmo

0.78

0.21

1.0

1.2

—

Dental caries, including avohilmo

1.28

0.21

1.1

—

Impacted teeth

0.00

0.21

0.0

1.1

—

Malignant neoplasm of corpus uteri

0.00

0.21

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.21

0.0

1.0

—

Personal history of malignant neoplasm

0.00

0.21

0.0

1.0

—

Malignant neoplasm of corpus uteri, including Hilmo

0.00

0.21

0.0

1.0

—

Benign neoplasm: Stomach

0.00

0.21

0.0

1.0

—

Sudden idiopathic hearing loss

0.00

0.21

0.0

1.1

—

Achilles tendinitis

0.00

0.21

0.0

1.1

—

Arthropathic psoriasis

0.00

0.21

0.0

1.0

—

Lichen sclerosus et atrophicus

0.00

0.21

0.0

1.0

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.1

—

Other/unspecified rheumatoid arthritis

0.00

0.21

0.0

1.0

—

Psoriatic and enteropathic arthropathies

0.00

0.21

0.0

1.1

—

Scabies, including avohilmo

0.00

0.21

0.0

1.2

—

Secondary uncertain malignant neoplasm

0.00

0.21

0.0

1.0

—

Dermatophytosis

0.00

0.21

0.0

1.1

—

Special screening examination for other diseases and disorders

0.00

0.21

0.0

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.21

0.0

1.1

—

Other condition

0.00

0.21

0.0

1.1

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.21

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

0.21

0.0

1.1

—

Glomerular diseases

0.00

0.21

0.0

1.1

—

Cardiomyopathy

0.00

0.21

0.0

1.1

—

Pediculosis, acariasis and other infestations, including avohilmo

0.00

0.21

0.0

1.2

—

Bacterial Sepsis

1.18

0.21

1.4

1.1

—

Other hammer toe(s) (acquired)

0.00

0.21

0.0

1.1

—

Endometriosis of pelvic peritoneum

0.00

0.21

0.0

1.0

—

Methotrexate

0.00

0.21

0.0

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

0.21

0.0

1.1

—

Malignant melanoma of skin, including Hilmo

0.00

0.21

0.0

1.0

—

Malignant melanoma

0.00

0.21

0.0

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

1.2

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.21

0.0

1.2

—

D07AA Corticosteroids, weak (group I)

0.00

0.21

0.0

1.1

—

Diabetic retinopathy, strict definition

0.00

0.20

0.0

1.1

—

Use of donepezil

0.00

0.20

0.0

1.0

—

Inguinal hernia

1.25

0.20

1.0

1.2

—

Lichen planus

0.00

0.20

0.0

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

0.00

0.20

0.0

1.0

—

Radiculopathy

0.00

0.20

0.0

1.1

—

Ulcerative colitis (strict definition, require KELA)

0.00

0.20

0.0

1.1

—

Diseases of inner ear

1.25

0.20

1.2

1.1

—

Acute appendicitis, no complications

1.24

0.20

1.2

—

Biguanides

1.23

0.20

1.1

—

Type 2 diabetes, strict (exclude DM1)

1.22

0.19

1.1

—

Type 2 diabetes, definitions combined

1.22

0.19

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.17

0.19

1.0

1.1

—

Dental operations

1.24

0.19

1.1

—

Chronic periodontitis, complicated

1.15

0.19

1.0

1.1

—

Type 2 diabetes

1.22

0.19

1.1

—

Disorders of sclera, cornea, iris and ciliary body

1.13

0.18

1.2

1.1

—

Cerebrovascular diseases

1.13

0.17

1.0

1.1

—

Lumbar disc prolapse

1.13

0.17

1.0

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.20

0.17

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.13

0.17

1.1

—

External causes of morbidity and mortality

1.18

0.17

1.1

1.3

—

Neoplasms

1.17

0.17

1.3

1.2

—

Chronic diseases of tonsils and adenoids

1.17

0.17

1.6

1.1

—

Diabetes, varying definitions

1.20

0.16

1.1

1.2

—

Codeine

1.23

0.16

1.1

1.2

—

Other disorders of skin and subcutaneous tissue

1.14

0.16

1.3

1.1

—

Diabetes mellitus

1.19

0.16

1.1

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

1.10

0.16

1.0

1.2

—

Complications of medical and surgical care

1.11

0.16

1.0

1.1

—

Caries of dentine, including avohilmo

1.12

0.15

1.1

—

Conjunctivitis (acute, non atopic), including avohilmo

1.19

0.15

1.3

1.1

—

Diseases of the ear and mastoid process

0.83

0.15

1.3

1.1

—

1.18

0.15

1.2

1.1

—

Chronic periodontitis, including avohilmo

1.18

0.14

1.2

1.1

—

Gonarthrosis,primary

0.83

0.14

1.0

1.1

—

Periodontitis

1.18

0.14

1.2

1.1

—

Other (not insulin) diabetes medications

1.17

0.13

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

1.15

0.10

1.1

1.2

—

Chronic apical periodontitis

1.14

0.10

1.1

1.2

—

Any event in cancer register

1.17

0.10

1.3

1.1

—

Dementia, including avohilmo

1.18

0.10

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.14

0.10

1.0

1.1

—

Organic, including symptomatic, mental disorders

1.10

0.10

1.0

1.1

—

Caries of enamel

1.14

0.09

1.2

1.1

—

Open wound of head

1.09

0.09

1.0

1.2

—

Provisional assignment of new diseases of uncertain etiology

1.08

0.09

1.0

1.1

—

Codes for special purposes

1.08

0.09

1.0

1.1

—

Myocardial infarction

1.06

0.09

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.14

0.09

1.3

1.1

—

Insulin, intermediate and long-acting

1.05

0.09

1.0

1.2

—

Glaucoma

1.04

0.09

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

1.03

0.09

1.0

1.1

—

Other diseases of hard tissues of teeth

1.11

0.09

1.2

1.1

—

Major coronary heart disease event excluding revascularizations

1.13

0.09

1.0

1.1

—

Persons encountering health services for examination and investigation

1.07

0.09

1.2

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.09

0.08

1.0

1.1

—

Acute tubulo-interstitial nephritis

1.05

0.08

1.2

1.1

—

Gonarthrosis, primary, with knee surgery

1.04

0.08

1.0

1.1

—

Dermatophytosis, including avohilmo

0.80

0.08

1.0

1.2

—

Diseases of the eye and adnexa

1.06

0.08

1.1

1.2

—

Leiomyoma of uterus

1.06

0.08

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

1.06

0.08

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

1.09

0.08

1.0

1.2

—

Appendectomy

1.09

0.08

1.1

1.2

—

Other neurological diseases

1.06

0.08

1.0

1.1

—

Injuries to the elbow and forearm

0.83

0.07

1.0

1.2

—

Disorders of choroid and retina

1.10

0.07

1.0

1.1

—

Malignant neoplasm

1.08

0.07

1.3

1.1

—

Malignant neoplasm

1.08

0.07

1.3

1.1

—

Exposure to other specified factors

0.86

0.07

1.0

1.2

—

Malignant neoplasm, including Hilmo

1.05

0.07

1.3

1.1

—

Malignant neoplasm, wide definition

1.05

0.07

1.3

1.1

—

Dorsopathies

0.84

0.07

1.6

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.12

0.07

1.5

1.1

—

Sleep disorders

0.86

0.07

1.3

1.1

—

Complications of surgical and medical care, not elsewhere classified

0.87

0.06

1.0

1.1

—

COPD/asthma related infections

1.10

0.04

1.2

1.1

—

COPD/asthma/ILD related infections

1.10

0.04

1.2

1.1

—

Diabetes medication

1.07

0.01

1.1

1.2

—

Mycoses, including avohilmo

1.07

0.01

1.1

1.2

—

Falls/tendency to fall

1.06

0.00

1.1

1.2

—

Other bacterial diseases

1.03

0.00

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

1.06

0.00

1.0

1.2

—

Diseases of the skin and subcutaneous tissue

1.02

0.00

1.1

—

Bronchitis

1.00

0.00

1.0

1.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.04

0.00

1.0

1.2

—

Other congenital malformations of the digestive system

0.00

0.0

1.0

—

Dilated cardiomyopathy

0.00

0.0

1.1

—

Cholecystitis

0.00

0.0

1.0

—

Other symptoms and signs involving general sensations and perceptions

0.00

0.0

1.0

—

Cholesteatoma of middle ear

0.00

0.0

1.0

—

Other specified/unspecified hearing loss

0.00

0.0

1.0

—

Other salmonella infections

0.00

0.0

1.0

—

0.00

0.0

1.2

—

Problems related to lifestyle

0.00

0.0

1.0

—

Other orthopaedic follow-up care

0.00

0.0

1.0

—

Other problems related to primary support group, including family circumstances

0.00

0.0

1.2

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.0

1.2

—

Melanocytic naevi of trunk

0.00

0.0

1.1

—

Contact with heat and hot substances

0.00

0.0

1.0

—

Superficial injury of thorax

0.00

0.0

1.1

—

Explicit bacterial Sepsis, including avohilmo

0.00

0.0

1.2

—

Suggestive for eosinophilic asthma

0.00

0.0

1.1

—

L01XX Other antineoplastic agents

0.00

0.0

1.0

—

Other secondary gonarthrosis

0.00

0.0

1.0

—

Artificial joint operation, meniscal resection

0.97

0.00

1.0

1.1

—

Right hemicolectomy

0.00

0.0

1.0

—

Polypectomy (DHB20)

0.00

0.0

1.0

—

Trochanteric bursitis

0.00

0.0

1.0

—

Other necrotizing vasculopathies

0.00

0.0

1.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

0.0

1.0

—

Pyogenic arthritis

0.00

0.0

1.2

—

Myeloproliferative diseases

0.00

0.0

1.0

—

Emotionally unstable personality disorder

0.00

0.0

1.2

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.0

—

ILD, hospital admission 2, with pulmonary infections

0.00

0.0

1.1

—

Tonsillectomy and adenotomy

0.97

0.00

2.0

1.1

—

Other disorders of glucose regulation and pancreatic internal secretion

0.00

0.0

1.0

—

Mucosal proctocolitis

0.00

0.0

1.0

—

Disorders of globe

0.00

0.0

1.0

—

Subarachnoid haemorrhage

0.00

0.0

1.0

—

Congenital malformations of the urinary system, including avohilmo

0.00

0.0

1.0

—

Other congenital malformations of skin, including avohilmo

0.00

0.0

1.0

—

Streptococcal septicaemia

0.00

0.0

1.0

—

Other maternal disorders predominantly related to pregnancy

0.99

0.00

1.2

1.1

—

Erysipelas

0.98

0.00

1.0

1.1

—

Injury of unspecified body region

0.00

-0.00

0.0

1.0

—

Familial hypercholesterolemia

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of pancreas, including Hilmo

0.00

-0.00

0.0

1.0

—

Obesity

0.90

-0.00

1.0

1.1

—

Extreme obesity with alveolar hypoventilation

0.00

-0.00

0.0

1.0

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

-0.00

0.0

1.0

—

Solid cancers, including Hilmo

0.95

-0.00

1.3

1.1

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Psoriatic arthropathies, ICD10

0.00

-0.00

0.0

1.0

—

Haemangioma, any site

0.00

-0.00

0.0

1.0

—

Synovial cyst of popliteal space [Baker]

0.00

-0.00

0.0

1.0

—

Non-follicular lymphoma

0.00

-0.00

0.0

1.0

—

Open wound of forearm

0.00

-0.00

0.0

1.0

—

Explicit bacterial Sepsis

0.00

-0.00

0.0

1.2

—

Ankylosing spondylitis, ICD10

0.00

-0.00

0.0

1.2

—

Childhood allergy (age < 16)

0.00

-0.00

0.0

2.0

—

Other bursopathies

0.00

-0.00

0.0

1.0

—

Unspecified dementia

0.00

-0.00

0.0

1.0

—

Accidents

1.00

-0.00

1.1

1.2

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

-0.00

0.0

1.0

—

Other salmonella infections, including avohilmo

0.00

-0.00

0.0

1.0

—

Biomechanical lesions, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Exposure to other and unspecified inanimate mechanical forces

0.00

-0.00

0.0

1.0

—

Other retinal disorders

1.03

-0.00

1.0

1.1

—

Foreign body entering into or through eye or natural orifice

0.00

-0.00

0.0

1.0

—

Corns and callosities

0.00

-0.00

0.0

1.0

—

Etanercept

0.00

-0.00

0.0

1.0

—

Chalazion

0.00

-0.00

0.0

1.0

—

Decubitus ulcer and pressure area

0.00

-0.00

0.0

1.0

—

Divergent concomitant strabismus

0.00

-0.00

0.0

1.0

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

1.0

—

Vestibular neuronitis

0.00

-0.00

0.0

1.2

—

Dermatitis due to substances taken internally

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system, including avohilmo

0.00

-0.00

0.0

1.0

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

-0.00

0.0

1.0

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

-0.00

0.0

1.0

—

Other erythematous conditions

0.00

-0.00

0.0

1.0

—

Other external causes of accidental injury

1.00

-0.00

1.1

1.3

—

Other misadventures during surgical and medical care

0.00

-0.00

0.0

1.0

—

Attention to artificial openings

0.00

-0.00

0.0

1.0

—

Examination and encounter for administrative purposes

0.00

-0.00

0.0

1.0

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

-0.00

0.0

1.0

—

Diseases of pulp and periapical tissues and dental caries

1.00

-0.00

1.1

—

Pedestrian injured in transport accident

0.00

-0.00

0.0

1.0

—

Artificial opening status

0.00

-0.00

0.0

1.0

—

Other pleural conditions

0.00

-0.00

0.0

1.1

—

Impacted maxillary molar

0.00

-0.00

0.0

1.2

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Cysts of oral region, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Diseases of oral cavity, salivary glands and jaws

0.92

-0.00

1.2

1.1

—

Lung diseases due to external agents

0.00

-0.00

0.0

1.0

—

Heart failure,strict

0.97

-0.00

1.0

1.1

—

Insulin medication

0.96

-0.00

1.0

1.2

—

Other and unspecified erythematous conditions

0.00

-0.00

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

1.1

—

Nummular dermatitis

0.00

-0.00

0.0

1.1

—

Other epidermal thickening

0.00

-0.00

0.0

1.0

—

Valvular operations

0.00

-0.00

0.0

1.1

—

Invasive ventilation

0.00

-0.00

0.0

1.0

—

Tooth eruption problems

0.00

-0.00

0.0

1.1

—

Early lumbar disc prolapse, operated

0.00

-0.00

0.0

1.3

—

Diabetic neuropathy

0.00

-0.00

0.0

1.1

—

Foreign body in respiratory tract

0.00

-0.00

0.0

1.0

—

Other and unspecified glaucoma

0.00

-0.00

0.0

1.0

—

Hypermetropia

0.00

-0.00

0.0

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

0.94

-0.00

1.0

1.2

—

All-cause Heart Failure

0.91

-0.00

1.0

1.1

—

Colon adenocarcinoma, helper endpoint

0.00

-0.00

0.0

1.1

—

Tuberculosis, IBD comorbidity

0.00

-0.00

0.0

1.0

—

Diffuse large B-cell lymphoma, helper endpoint

0.00

-0.00

0.0

1.0

—

Gonarthrosis

0.97

-0.00

1.0

1.1

—

Pneumonitis due to solids and liquids

0.00

-0.00

0.0

1.0

—

Pneumothorax

0.00

-0.00

0.0

1.0

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

1.2

—

Acute nasopharyngitis (common cold)

0.00

-0.00

0.0

1.1

—

Chronic suppurative otitis media, including avohilmo

0.00

-0.00

0.0

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.00

-0.00

0.0

1.0

—

Impacted cerumen

0.00

-0.00

0.0

1.0

—

Thrombocytopenia, unspecified

0.00

-0.00

0.0

1.0

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

-0.00

0.0

1.0

—

Otosclerosis

0.00

-0.00

0.0

1.0

—

Paralytic strabismus

0.00

-0.00

0.0

1.0

—

Chronic suppurative otitis media

0.00

-0.00

0.0

1.0

—

Presbyopia

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of head and neck, including Hilmo

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.0

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

-0.00

0.0

1.0

—

Spontaneous rupture of synovium and tendon

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of rectum, including Hilmo

0.00

-0.00

0.0

1.0

—

Rash and other nonspecific skin eruption

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at lower leg level

0.00

-0.00

0.0

1.1

—

Postprocedural disorders of nervous system

0.00

-0.00

0.0

1.0

—

Polymyalgia rheumatica

0.00

-0.00

0.0

1.0

—

Psoriatic arthropathies

0.00

-0.00

0.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin, unspecified

0.00

-0.00

0.0

1.0

—

Lesion of ulnar nerve

0.00

-0.00

0.0

1.1

—

Heart failure, strict

0.89

-0.00

1.0

1.1

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

Degenerative macular diseases

0.00

-0.00

0.0

1.0

—

Myeloproliferative diseases (CML excluded)

0.00

-0.00

0.0

1.0

—

Unspecified/other endometriosis

0.00

-0.00

0.0

1.0

—

Glomerular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of ovary

0.00

-0.00

0.0

1.0

—

Other disorders of bladder

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of ovary, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of rectum

0.00

-0.00

0.0

1.0

—

Hydrocele

0.00

-0.00

0.0

1.0

—

Other specified and unspecified retinal disorders

0.00

-0.00

0.0

1.0

—

Glomerulonephritis

0.00

-0.00

0.0

1.1

—

Hydronephrosis

0.00

-0.00

0.0

1.0

—

Primary angle-closure glaucoma

0.00

-0.00

0.0

1.0

—

Nonischemic cardiomyopathy

0.00

-0.00

0.0

1.0

—

Hordeolum and other deep inflammation of eyelid

0.00

-0.00

0.0

1.0

—

Obesity and other hyperalimentation

0.89

-0.00

1.0

1.1

—

Idiopathic pulmonary fibrosis

0.00

-0.00

0.0

1.0

—

Cystic kidney disease

0.00

-0.00

0.0

1.0

—

Other disorders of nervous system

0.00

-0.00

0.0

1.0

—

Disorders of synovium and tendon

0.99

-0.00

1.0

1.1

—

Other appendicitis

0.00

-0.00

0.0

1.2

—

Astigmatism

0.00

-0.00

0.0

1.0

—

Other/unspecified synovitis and tenosynovitis

0.00

-0.00

0.0

1.0

—

Chronic hepatitis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other contact dermatitis

0.00

-0.00

0.0

1.0

—

Other and unspecified psoriasis

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Peripheral artery operations in Hilmo

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Parotid gland

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

-0.00

0.0

1.0

—

Benign neoplasm of major salivary glands

0.00

-0.00

0.0

1.0

—

Other local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

1.1

—

Dermatographic urticaria

0.00

-0.00

0.0

1.0

—

Injuries to unspecified part of trunk, limb or body region

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Benign neoplasm of middle ear and respiratory system

0.00

-0.00

0.0

1.0

—

Any death

1.00

-0.00

1.2

1.1

—

Non-allergic asthma

0.00

-0.00

0.0

1.0

—

Congenital malformations of genital organs

0.00

-0.00

0.0

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.00

-0.00

0.0

1.2

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

0.00

-0.00

0.0

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.00

-0.00

0.0

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.95

-0.00

1.2

1.0

—

Medical observation and evaluation for suspected diseases and conditions

0.91

-0.00

1.2

1.0

—

Multiple gestation

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of head and neck

0.00

-0.00

0.0

1.0

—

Other complications of labour and delivery, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of pancreas

0.00

-0.00

0.0

1.0

—

Diffuse large B-cell lymphoma

0.00

-0.00

0.0

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

0.00

-0.00

0.0

1.0

—

Visual field defects

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

0.00

-0.00

0.0

1.0

—

Solid cancers

0.96

-0.00

1.3

1.1

—

Amputation of toe

0.00

-0.00

0.0

1.0

—

Tuberculosis, wide

0.00

-0.00

0.0

1.0

—

Amputation

0.00

-0.00

0.0

1.1

—

Cardiomyopathies, Primary/intrinsic

0.00

-0.00

0.0

1.1

—

Cystic kidney disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Follicular lymphoma, hilmo

0.00

-0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

-0.00

0.0

1.0

—

Diffuse large B-cell lymphoma, including Hilmo

0.00

-0.00

0.0

1.0

—

Polycystic kidney disease

0.00

-0.00

0.0

1.0

—

Alcohol withdrawal state with delirium

0.00

-0.00

0.0

1.2

—

Recurrent dislocation of patella

0.00

-0.00

0.0

1.2

—

Lymphoid leukaemia

0.00

-0.00

0.0

1.0

—

Excessive attrition of teeth

0.88

-0.00

1.0

1.1

—

Statin medication

1.02

-0.00

1.0

1.2

—

Tuberculosis, wide, including avohilmo

0.00

-0.00

0.0

1.0

—

Perforation of tympanic membrane

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

-0.00

0.0

1.1

—

Other specified/unspecified bacterial intestinal infections

0.00

-0.00

0.0

1.0

—

Injury of eye and orbit

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

-0.00

0.0

1.0

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.1

—

Disturbances of smell and taste

0.00

-0.00

0.0

1.0

—

Other psoriatic arthropathies

0.00

-0.00

0.0

1.0

—

Injury of other and unspecified intrathoracic organs

0.00

-0.00

0.0

1.2

—

Streptococcal septicaemia, including avohilmo

0.00

-0.00

0.0

1.0

—

Twin gestation

0.00

-0.00

0.0

1.0

—

Thiazolidinediones

0.00

-0.00

0.0

1.0

—

Total colectomy operation

0.00

-0.00

0.0

1.0

—

Certain conditions originating in the perinatal period

0.00

-0.00

0.0

1.2

—

Ankylosing spondylitis

0.00

-0.00

0.0

1.2

—

Other obstructed labour

0.00

-0.00

0.0

1.1

—

Failed induction of labour

0.00

-0.00

0.0

1.2

—

Total colectomy

0.00

-0.00

0.0

1.0

—

Multiple delivery

0.00

-0.00

0.0

1.0

—

Disorders of psychological development

0.00

-0.00

0.0

1.1

—

Undefined dementia

0.00

-0.00

0.0

1.0

—

Additional codes for the location of defect, injury or illness

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Chloride [Moles/time] in 24 hour Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS